All News

Diabetes, Cardiovascular Risk Factors Linked to Early Declines in Cognition

July 16, 2020

New research provides an overview of the impact diabetes and cardiovascular risk factors can have on cognition in middle-aged patients.

Study Outlines Risk of Death, Cardiovascular Disease in Prediabetes

July 16, 2020

Results of a meta-analysis are detailing the current risk prediabetes poses on the cardiovascular health and overall well-being of patients.

Primary Care's Perception of Role in Thyroid Cancer Survivorship Care

July 15, 2020

New research is defining how primary care providers view their role in long-term survivorship care of patients with thyroid cancer.

Bariatric Surgery More Common, Less Expensive with Private Insurance

July 15, 2020

New research from the University of Georgia found private insurance was associated with a greater frequency of bariatric surgery and lower cost of surgery than public insurance.

Cardiac CT Exams Effect For Assessing Osteoporosis

July 14, 2020

This article originally appeared on

New Analysis Strengthens Cardiovascular Safety Profile of Abaloparatide

July 14, 2020

A new analysis is strengthening the safety profile of abaloparatide (Tymlos) in postmenopausal women to prevent risk of fracture.

DOACs Tied to Lower Osteoporotic Fracture Risk than Warfarin

July 13, 2020

A new analysis suggests DOAC use was associated with a lower risk of osteoporotic fracture than warfarin.

New Review Details Mortality Rates in Diabetics Since 1970

July 12, 2020

An analysis examining 5 decades of data is shedding light on mortality trends in diabetic patients from 1970-2016.

Increased Fasting Glucose Doubles COVID-19 Mortality Risk

July 11, 2020

Results of an analysis of more than 600 patients suggests increased fasting blood glucose was associated with a 2.3 times greater risk of 28-day mortality in COVID-19 patients.

Meta-Analysis Explores Cardiovascular, Renal Effects of SGLT2s and GLP-1s

July 10, 2020

New research is seeking to update previous analyses examining the cardiovascular and renal benefits of GLP-1 receptor agonists and SGLT2 inhibitors in patients with type 2 diabetes.